We currently do not have sufficient information about the CEO.
Key information
Christian Noel
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
5.1yrs
CEO ownership
n/a
Management average tenure
6yrs
Board average tenure
6.8yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Christian Noel's remuneration changed compared to Cryomass Technologies's earnings?
Date
Total Compensation
Salary
Company Earnings
Sep 30 2024
n/a
n/a
-US$9m
Jun 30 2024
n/a
n/a
-US$9m
Mar 31 2024
n/a
n/a
-US$14m
Dec 31 2023
US$682k
n/a
-US$13m
Sep 30 2023
n/a
n/a
-US$15m
Jun 30 2023
n/a
n/a
-US$15m
Mar 31 2023
n/a
n/a
-US$10m
Dec 31 2022
US$536k
US$387k
-US$10m
Sep 30 2022
n/a
n/a
-US$8m
Jun 30 2022
n/a
n/a
-US$10m
Mar 31 2022
n/a
n/a
-US$11m
Dec 31 2021
US$1m
US$240k
-US$10m
Compensation vs Market: Insufficient data to establish whether Christian's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Christian's compensation with company performance.
CEO
Christian Noel (48 yo)
5.1yrs
Tenure
US$681,940
Compensation
Mr. Christian Noel served as Vice President of National Sales and Portfolio Manager at Globevest Capital Ltd., and was previously the Head of National Sales since July 2014 until 2020. In 2014, he was admi...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Christian Noel
CEO & Director
5.1yrs
US$681.94k
no data
Philip Mullin
Chief Financial Officer
6.9yrs
US$420.00k
no data
Patricia Kovacevic
General Counsel
6.1yrs
US$319.44k
no data
Ryan Smith
Chief Operating Officer of Good Meds
6yrs
no data
no data
Stephen Schroeder
Consultant
no data
no data
no data
Caroline Lenardon
Consultant
no data
no data
no data
Janice Matthews
Consultant
no data
no data
no data
6.0yrs
Average Tenure
54yo
Average Age
Experienced Management: CRYM's management team is seasoned and experienced (6 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Christian Noel
CEO & Director
5.1yrs
US$681.94k
no data
Mark Radke
Independent Director
6.8yrs
US$50.51k
no data
Simon Langelier
Independent Director
4.3yrs
US$32.00k
no data
Mario Gobbo
Independent Director
6.8yrs
US$50.51k
no data
Delon Human
Independent Chairman of the Board
6.8yrs
US$87.53k
no data
6.8yrs
Average Tenure
66yo
Average Age
Experienced Board: CRYM's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/21 21:47
End of Day Share Price
2026/05/21 00:00
Earnings
2024/09/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cryomass Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.